1. Home
  2. VRAR vs PASG Comparison

VRAR vs PASG Comparison

Compare VRAR & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Glimpse Group Inc.

VRAR

The Glimpse Group Inc.

HOLD

Current Price

$1.03

Market Cap

21.9M

Sector

Technology

ML Signal

HOLD

PASG

Passage Bio Inc.

HOLD

Current Price

$10.00

Market Cap

29.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VRAR
PASG
Founded
2016
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.9M
29.3M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
VRAR
PASG
Price
$1.03
$10.00
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
4
Target Price
$2.62
$34.50
AVG Volume (30 Days)
96.7K
44.2K
Earning Date
11-13-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$9,488,209.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$72.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
16.60
N/A
52 Week Low
$0.96
$5.12
52 Week High
$7.00
$20.20

Technical Indicators

Market Signals
Indicator
VRAR
PASG
Relative Strength Index (RSI) 38.07 58.34
Support Level $1.03 $8.23
Resistance Level $1.16 $10.71
Average True Range (ATR) 0.08 0.89
MACD 0.01 0.16
Stochastic Oscillator 0.00 70.67

Price Performance

Historical Comparison
VRAR
PASG

About VRAR The Glimpse Group Inc.

The Glimpse Group Inc is a diversified immersive technology platform company, focused on providing enterprise solutions in virtual reality (VR), augmented reality (AR), and spatial computing. The company operates multiple subsidiaries that develop VR and AR software and services across various industries, including corporate training, education, healthcare, government, defense, marketing, retail, and financial services. It also offers AI-driven spatial computing platforms that support simulations, social VR, behavioral health, and corporate events. The Company reports its revenues in three categories: Software Services, Software License and Software-as-a-Service (SaaS), and Royalty Income, with the majority being from the Software Services category.

About PASG Passage Bio Inc.

Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.

Share on Social Networks: